nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.12.2015 | Image of the Month

A case of Fahr’s disease examined by multi-modal imaging

verfasst von: Ferdinando Calabria, Gabriele Ciccariello, Carmela Falcone, Giuseppe Lucio Cascini, Orazio Schillaci

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 13/2015

Einloggen, um Zugang zu erhalten

Excerpt

…

Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001;28:266–72.CrossRefPubMed

Manyam BV. What is and what is not 'Fahr's disease'. Parkinsonism Relat Disord. 2005;11:73–80.CrossRefPubMed

König P. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry. 1989;15:459–68.CrossRef

Paghera B, Caobelli F, Giubbini R. 123I-ioflupane SPECT in Fahr disease. J Neuroimaging. 2013;23:157–8.CrossRefPubMed

Calabria F, Calabria E, Chiaravalloti A, Barbarisi M, Schillaci O. A case of intracranial meningioma detected by ¹⁸F-choline PET/CT and examined by PET/MRI fusion imaging. Rev Esp Med Nucl Imagen Mol. 2014;33:306–7.PubMed

Titel: A case of Fahr’s disease examined by multi-modal imaging
verfasst von: Ferdinando Calabria
Gabriele Ciccariello
Carmela Falcone
Giuseppe Lucio Cascini
Orazio Schillaci
Publikationsdatum: 01.12.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 13/2015
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-015-3162-y

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 13/2015

Long-term outcomes of 131Iodine mIBG therapy in metastatic gastrointestinal pancreatic neuroendocrine tumours: single administration predicts non-responders

The efficacy of 177Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumours: a meta-analysis

99mTc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials

Gastric injury from 90Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients

Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients